Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.
AUTOR(ES)
Jacobus, N V
RESUMO
The in vitro activity of trospectomycin (U-63366; 6'-n-propyl spectinomycin pentahydrate sulfate) was evaluated against 189 clinical isolates of the Bacteroides fragilis group and 65 Bacteroides species isolates. At less than or equal to 8 micrograms/ml, the activity of trospectomycin compared favorably with those of clindamycin and cefoxitin against B. fragilis, Bacteroides distasonis, and Bacteroides vulgatus, and there was no cross resistance to these three drugs among the strains of the B. fragilis group. All the Bacteroides species were susceptible to trospectomycin. The results of this in vitro study indicate that trospectomycin possesses excellent activity against Bacteroides species.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172225Documentos Relacionados
- Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
- Plasmid analyses in clinical isolates of Bacteroides fragilis and other Bacteroides species.
- In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species.
- Adherence of Bacteroides fragilis group species.
- Superoxide dismutase in Bacteroides fragilis and related Bacteroides species.
